Ubie

What Ubie does

Ubie is a Tokyo-headquartered health-tech company founded in 2017 that builds AI-powered healthcare prediction and patient engagement tools. Its core products include an AI Symptom Checker used by over 1,000 medical institutions worldwide and millions of monthly users, an AI-driven Patient Intake Service that automates pre-consultation data collection, and a Medical Data Platform connecting patients, healthcare providers, and pharmaceutical companies in Japan and the United States. The portfolio expanded materially in 2026 to include Consult, a doctor-approved chat-based LLM trained on over 50,000 peer-reviewed publications and validated by more than 50 medical specialists, and Smart Support, an AI-powered digital front door platform co-developed with Mayo Clinic that integrates chat and voice interfaces with symptom assessment, triage, and self-scheduling. The company has also launched Ubie Self-Serve, a targeted advertising platform for pharmaceutical companies.

The underlying technology combines large language models, generative AI, and predictive analytics built on a clinically validated symptom-to-condition pipeline. Ubie reports higher triage accuracy than generic LLMs, which it cites as correctly identifying conditions in fewer than 34.5% of cases. A wholly-owned US subsidiary established in 2022 supports international expansion, with reported metrics of 13 million global monthly users as of March 2026 (2 million in the US), 25% month-over-month user growth, and an 85% increase in US organic users since 2024. Cumulative funding since 2017 exceeds $125 million across rounds led by Japanese financial institutions (Dai-ichi Life, Norinchukin Capital, MUFG, Mizuho, Sumitomo Mitsui Trust), and corporate investors including Google, NTT DOCOMO Ventures, Seven-Eleven Japan, and Japan Post Capital.

The business model combines three revenue streams: B2B subscriptions from healthcare institutions using the Symptom Checker and Patient Intake Service, advertising revenue from the Ubie Self-Serve platform (launched June 2026 with $100/day entry pricing for pharmaceutical advertisers targeting by symptom and disease prediction), and data/partnership programs connecting patients, providers, and pharmaceutical companies. The company serves 1,000+ medical institutions, millions of B2C users across Japan and the US, and counts Mayo Clinic as a flagship enterprise partner alongside major Japanese banks and corporate investors as financial backers.

Name

Ubie

Legal name

Ubie株式会社

Website

https://ubie.life

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

251–500 employees

Short description

Ubie is a Tokyo-based health-tech company founded in 2017 that builds AI-powered symptom checking, patient intake, and triage tools used by 1,000+ medical institutions and 13 million monthly users, monetizing via B2B subscriptions, pharma advertising, and data partnerships across Japan and the US.

Ownership category

akta.pro rank

Product category

Healthcare AI Platform

NAICS

Software Publishers (5132), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)

akta.pro secondary industries

Prompt Engineering, Orchestration & LLMOps Tooling (HDAAACAD), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

Keywords

• AI symptom checker
• Patient intake automation
• Healthcare AI platform
• Medical data platform
• AI triage chatbot

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. B2B Healthcare Solutions: Provides AI-powered tools to healthcare institutions including symptom checker and patient intake services used by over 1,000 medical institutions worldwide
2. Healthcare Advertising Platform: Ubie Self-Serve advertising platform enabling pharmaceutical companies to target patients based on symptoms, disease predictions, and specialty interests within AI-driven healthcare experiences
3. Pharmaceutical Partnerships: Medical data platform connecting patients, medical institutions, and pharmaceutical companies to improve healthcare information sharing and operational efficiency

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Ubie develops and operates an AI-powered healthcare prediction platform built on large language models and generative AI. Its commercial offerings include a consumer-facing AI Symptom Checker, an AI Patient Intake Service deployed at more than 1,000 medical institutions worldwide, an LLM-based patient consultation product (Consult), an enterprise digital front-door platform (Smart Support, co-developed with Mayo Clinic), and a self-serve healthcare advertising platform for pharmaceutical buyers.

Product overview

Ubie is a health technology company offering a suite of AI-powered healthcare prediction tools. The core products include the Symptom Checker and Patient Intake Service, supported by a Medical Data Platform connecting patients, medical institutions, and pharmaceutical companies. The portfolio expands into patient-facing solutions like Consult (LLM-based chatbot) and Smart Support (AI triage and scheduling platform developed with Mayo Clinic), plus Ubie Self-Serve for pharmaceutical advertising. The company serves millions of monthly users across Japan and the US.

Differentiator

Problem solved

Functional benefit

Brands

• Ubie Consult: Doctor-approved, chat-based LLM built on clinically-validated Symptom Checker to help patients decide whether to self-manage or seek medical care.
• Ubie Self-Serve
• Ubie Smart Support
• Ubie Symptom Checker

Products and services

• Ubie Symptom Checker AI-powered symptom checker that analyzes patient symptoms to predict likely conditions and recommend next steps, used by consumers and by over 1,000 medical institutions worldwide.
• Patient Intake Service AI-powered patient intake solution that automates collection of patient information, medical history, and symptom data prior to consultations, improving operational efficiency for healthcare providers.
• Medical Data Platform Platform connecting patients, medical institutions, and pharmaceutical companies to improve healthcare information sharing, medical data exchange, and operational efficiency in Japan and the US.
• Consult Doctor-approved, chat-based LLM built on Ubie's clinically-validated Symptom Checker that helps patients decide whether to self-manage or seek medical care, with content validated by over 50 medical specialists.
• Smart Support AI-powered digital front door platform co-developed with Mayo Clinic that integrates chat and voice interfaces with clinically validated symptom assessment, triage, and self-scheduling, with planned chronic disease management capabilities.
• Ubie Self-Serve Self-serve targeted healthcare advertising platform enabling pharmaceutical companies and media buyers to reach patients based on symptoms, disease predictions, and specialty interests within AI-driven healthcare experiences.

Quantifiable outcome

• 25% month-over-month growth in global monthly users to 13 million (March 2026)
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core, minor and flagship.

• AI Safety Institute (AISI)coreStrategic or Co-development Partner · 3 April 2026Ubie's working leader collaborated with AISI to develop 'Guidelines for AI Safety Evaluation Perspectives in the Healthcare Sector', positioning Ubie as a leader in healthcare AI safety standards.
• EFPIA Japan (European Federation of Pharmaceutical Industries and Associations)minorGTM or Marketing Partner · 10 March 2026One of three major pharmaceutical industry associations confirming as sponsors of Ubie Pharma Summit 2026 conference to be held May 13-14, 2026 in Tokyo, focused on AI and information technology integration in pharmaceutical industry.
• Japan Pharmaceutical Manufacturers Association (JPMA)minorGTM or Marketing Partner · 10 March 2026Japanese pharmaceutical industry association sponsoring Ubie Pharma Summit 2026, participating in joint panel discussion on patient-centered healthcare solutions using AI.
• PhRMA (Pharmaceutical Research and Manufacturers of America)minorGTM or Marketing Partner · 10 March 2026US pharmaceutical industry association confirming as sponsor of Ubie Pharma Summit 2026 and participating in joint panel discussion alongside EFPIA Japan and JPMA.
• Mayo ClinicflagshipStrategic or Co-development Partner · 12 February 2026Ubie announced collaboration with Mayo Clinic to co-develop Ubie Smart Support, an AI-powered platform designed to unify fragmented digital healthcare access points into a single enterprise-grade patient experience. The platform integrates chat and voice interfaces with clinically validated symptom assessment, triage, and self-scheduling capabilities. Collaboration followed Ubie's 30-week pilot in Mayo Clinic's Platform Accelerate program.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Ada Health: Direct competitor in AI-powered symptom checking and triage. Ada Health offers a consumer symptom assessment app and enterprise partnerships with health systems and insurers, mirroring Ubie's patient-facing and B2B go-to-market.
• Babylon Health: Pioneer in AI symptom triage and digital care delivery, now operating as Babylon by Evernorth. Direct comparable on AI symptom checker and triage layer integrated into health system and payer offerings.
• K Health: AI-driven primary care platform with symptom-to-condition chatbot and affiliated clinical services. Compares on AI symptom assessment combined with care navigation and telemedicine in the US.
• Mediktor: Spain-based AI symptom checker sold to health systems, insurers, and pharma. Direct competitor in white-label clinical triage AI for hospital digital front doors.
• Buoy Health: US-based AI symptom checker and care navigation tool offered to health plans and providers. Directly comparable on AI triage and digital front-door orientation.

Emerging players

• Suki AI: AI clinical documentation and ambient scribe for physicians. Adjacent competitor for the generative AI documentation feature Ubie launched in 2023, competing for the same clinical workflow budget.
• Doximity: Physician-facing digital platform with growing AI scribe tools (Doximity GPT). Adjacent competitor for clinician mind-share and digital workflow budgets.

Broad incumbents

• Microsoft Cloud for Healthcare: Microsoft's broader healthcare platform offering AI capabilities for health systems, including clinician copilots and patient engagement. Represents the strategic incumbent threat with deeper health system distribution than Ubie.
• Google Health / MedLM: Google's healthcare AI initiatives including MedLM and Fitbit health services. Notable as both a Ubie investor and potential platform competitor given Google's foundation model and cloud distribution advantages.
• WebMD: Legacy consumer health information and symptom-checker platform with massive consumer traffic. Indirect competitor for consumer symptom assessment and pharma advertising dollars.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/UbieCorp_JP
• Facebookfacebook.com/ubie.inc
• LinkedInlinkedin.com/company/ubie-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds13 records

Investors22 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ubie